Avalo Therapeutics, Inc.
Pharmaceutical company · Wayne, Pennsylvania, United States · Nasdaq: AVTX
Avalo Therapeutics, Inc. is a pharmaceutical company headquartered in Wayne, Pennsylvania, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker AVTX. It has reported private securities offerings to the US SEC, most recently $131 million sold in a notice filed in 2024.
Avalo Therapeutics at a glance
What does Avalo Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $130.6 million sold (2024).
Frequently asked questions about Avalo Therapeutics
Where is Avalo Therapeutics headquartered?
Avalo Therapeutics, Inc. is headquartered in Wayne, Pennsylvania, United States.
What does Avalo Therapeutics do?
Avalo Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Avalo Therapeutics a public company?
Yes. Avalo Therapeutics, Inc. trades on Nasdaq under the ticker AVTX.
When was Avalo Therapeutics founded?
The earliest incorporation on record for Avalo Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Aclaris Therapeutics, Inc.Wayne, Pennsylvania, United States
- Palvella Therapeutics, Inc.Wayne, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.